1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
(
- Contribution to journal › Article
- 2015
-
Mark
Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice.
(
- Contribution to journal › Article
- 2007
-
Mark
Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis.
(
- Contribution to journal › Article
- 2003
-
Mark
Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells.
(
- Contribution to journal › Article
- 1999
-
Mark
Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation?
(
- Contribution to journal › Article
- 1997
-
Mark
Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma
(
- Contribution to journal › Article